Mauricio Anhesini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mauricio Anhesini has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Wanderley Marques Bernardo
Universidade de São Paulo, Brazil
10 shared publications - Haroldo Katayama
Grupo de M.B. E, Brasil
9 shared publications - Ighor Alexander Zamuner Spir
Grupo de M.B. E, Brasil
9 shared publications - Pericles Otani
Grupo de M.B. E, Brasil
9 shared publications - Adriano Anzai
Guidelines Program of the Brazilian Medical Association, Brazil
7 shared publications - Mary Martins Nery
Guidelines Program of the Brazilian Medical Association, Brazil
7 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (1) , e2025D721
Durvalumab in advanced biliary tract cancer
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (1) , e2025D721
Open AccessDurvalumab in advanced biliary tract cancer
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (2) , e2023D702
Treatment of refractory low back pain due to arthrosis of the lumbar spine with or without spondylolisthesis using anterior lumbar interbody fusion (ALIF)
Low back pain due to osteoarthritis is among the most common causes of medical consultations, and in approximately 85% of cases, the origin of back pain is unknown. Osteoarthritis is a degenerative and progressive musculoskeletal disorder, a common condition involving joint surfaces, which can evolve into a debilitating condition due to pain and restricted movement.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (2) , e2023D702
Open AccessTreatment of refractory low back pain due to arthrosis of the lumbar spine with or without spondylolisthesis using anterior lumbar interbody fusion (ALIF)
Low back pain due to osteoarthritis is among the most common causes of medical consultations, and in approximately 85% of cases, the origin of back pain is unknown. Osteoarthritis is a degenerative and progressive musculoskeletal disorder, a common condition involving joint surfaces, which can evolve into a debilitating condition due to pain and restricted movement.
- Open Access
- 1 February 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (2) , 207-212
Use of programmable valve versus fixed pressure valve in the treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis
- 1 February 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (2) , 207-212
Open AccessUse of programmable valve versus fixed pressure valve in the treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (8) , e2023D698
Use of intra-articular hyaluronic acid in knee osteoarthritis or osteoarthritis
With an estimated worldwide prevalence of 3%, osteoarthritis (OA) is among the most frequent problems in elderly clinical practice. For a long time, it was considered a disease that only involved wear and tear of the articular cartilage, but today, with the advances in the understanding of the disease, the understanding is that the pathophysiological changes involve the joints as a whole (cartilage, bone, synovial membrane, ligaments, adipose tissue, and meniscus), as well as pain processing nerve pathways. Changes may arise due to internal (obesity) and external mechanical loads, joint misalignment (genu varus and genu valgus), metabolic, and genetic factors. Excessive load on the bone can result in spinal cord injuries with microfractures, necrosis, fibrosis, and adipocytes, all suggestive of damage and remodeling in the injured area. Synovitis is commonly observed, and it plays an important role in joint destruction. Factors with pro-inflammatory cytokines (interleukin-6 [IL6]), monocyte chemoattractant protein, vascular endothelial growth factor, protein, and monokine induced by interferon γ are responsible for the progressive destruction due to the stimulation of degradation enzymes, and the growth factors stimulate the production of matrix for remodeling but end up promoting the formation of osteophytosis, thus contributing to subchondral sclerosis. Cytokines are not only the drivers of joint destruction but also potential targets for intervention to modify disease progression. Cartilage, as the only tissue without vascular, nervous, or lymphatic supply, has properties that condition its low intrinsic repair capacity, making repair difficult1 1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568-78. https://doi.org/10.1001/jama.2020.22171 https://doi.org/https://doi.org/10.1001/... .
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (8) , e2023D698
Open AccessUse of intra-articular hyaluronic acid in knee osteoarthritis or osteoarthritis
With an estimated worldwide prevalence of 3%, osteoarthritis (OA) is among the most frequent problems in elderly clinical practice. For a long time, it was considered a disease that only involved wear and tear of the articular cartilage, but today, with the advances in the understanding of the disease, the understanding is that the pathophysiological changes involve the joints as a whole (cartilage, bone, synovial membrane, ligaments, adipose tissue, and meniscus), as well as pain processing nerve pathways. Changes may arise due to internal (obesity) and external mechanical loads, joint misalignment (genu varus and genu valgus), metabolic, and genetic factors. Excessive load on the bone can result in spinal cord injuries with microfractures, necrosis, fibrosis, and adipocytes, all suggestive of damage and remodeling in the injured area. Synovitis is commonly observed, and it plays an important role in joint destruction. Factors with pro-inflammatory cytokines (interleukin-6 [IL6]), monocyte chemoattractant protein, vascular endothelial growth factor, protein, and monokine induced by interferon γ are responsible for the progressive destruction due to the stimulation of degradation enzymes, and the growth factors stimulate the production of matrix for remodeling but end up promoting the formation of osteophytosis, thus contributing to subchondral sclerosis. Cytokines are not only the drivers of joint destruction but also potential targets for intervention to modify disease progression. Cartilage, as the only tissue without vascular, nervous, or lymphatic supply, has properties that condition its low intrinsic repair capacity, making repair difficult1 1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568-78. https://doi.org/10.1001/jama.2020.22171 https://doi.org/https://doi.org/10.1001/... .
- Open Access
- 5 December 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (12) , 1611-1618
Comparison between ceramic-on-polyethylene versus metal-on-polyethylene prostheses in Total Hip Arthroplasties: a systematic review and meta-analysis
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient.
- 5 December 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (12) , 1611-1618
Open AccessComparison between ceramic-on-polyethylene versus metal-on-polyethylene prostheses in Total Hip Arthroplasties: a systematic review and meta-analysis
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient.
- Open Access
- 7 October 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (9) , 1130-1153
Sugammadex in awakening from general anesthesia: systematic review and meta-analysis
- 7 October 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (9) , 1130-1153
Open AccessSugammadex in awakening from general anesthesia: systematic review and meta-analysis
- Open Access
- 19 September 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (8) , 982-986
Use of absorbable versus nonabsorbable anchors in the treatment of glenohumeral instability
- 19 September 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (8) , 982-986
Open AccessUse of absorbable versus nonabsorbable anchors in the treatment of glenohumeral instability
- Open Access
- 1 December 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (12) , 1620
Amyloidosis: the use of the Daratumumab
ANSWER: The use of daratumumab in patients with clinical symptoms of amyloidosis currently should not be recommended due to the weakness of the evidence available to support it. 1
- 1 December 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (12) , 1620
Open AccessAmyloidosis: the use of the Daratumumab
ANSWER: The use of daratumumab in patients with clinical symptoms of amyloidosis currently should not be recommended due to the weakness of the evidence available to support it. 1
- Open Access
- 1 November 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (11) , 1468-1471
Use of daratumumab in patients with amyloidosis
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.
- 1 November 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (11) , 1468-1471
Open AccessUse of daratumumab in patients with amyloidosis
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.
- Open Access
- 1 April 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (4) , 392-399
Is the use of microwave ablation more effective and/or safe that radiofrequency ablation in the treatment of hepatocellular carcinoma?
The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.
- 1 April 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (4) , 392-399
Open AccessIs the use of microwave ablation more effective and/or safe that radiofrequency ablation in the treatment of hepatocellular carcinoma?
The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.